acquired
Stage
1
Investors
About
A biopharmaceutical company focused on developing and commercializing cenobamate, an investigational antiepileptic drug, in the European market.
Explore Arvelle's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.